This idea is corroborated by previous reports showing an important role for PEAKs in the induction of epithelial to mesenchyme transition of other cancer cells [19,21], and our results showing a diminution of the elongated morphology of CRC cells upon PEAK2 silencing. The gene discussed is PRAG1; the disease is cancer.